MULTIPLE MYELOMA WITH A MONOCLONAL PEAK AT BETA-GLOBULIN FRACTION: CASE REPORT

Authors

  • Rodrigo Montandon Esteves Pires
  • Ana Paula Fernandes de Almeida
  • Andréa Mariotto
  • Luís Paulo Beltrame
  • Cláudia Valéria Pereira
  • Rubens Bonfiglioli
  • José Roberto Provenza

Keywords:

multiple myeloma, blood protein electrophoresis, beta-globulins

Abstract

The present work relates a case of a 82-year-oldpatient, with sudden backpain and crumbling of 7th thoracic vertebra, whose serwn protein electrophoresis showed a monoclonal peak at the betaglobulin fraction, an unusual find that occurs only in 10% of Multiple Myeloma cases. The patient underwent a sternal bone marrow aspiration puncture. The myelogram showed 70% of isolated and aggregated plamocytes, some of them dysplasic and binucleated, compatible with Multiple Myeloma. Treatment with chemotherapy, using Alkeran and Prednisone, started in January 2000, and the patient soon presented clinical-laboratorial recovery.

Downloads

Download data is not yet available.

References

BART, R. et al. Histologic, biochemical and clinical parameters for monitoring multiple myeloma. Cancer, Philadelphia, v. 15, n. 10, p.2241-2250, 1991

BERGSAGEL, D.E. Plasma cell myeloma. In: WILLIANS, R.C. (Ed.). Hematology. 4.ed. New York: McGraw Hill, 1990. Capítulo 122, pH 101-1109, 11 14-1134.

BIRO, L.et al. Cytokine regulation of the acute phase protein levels in multiple myeloma. Eur J Clin Invest, Oxford, v. 28, n.8, p.679-686, 1998.

HAFERLACH, T., LOFFER, H. Prognostic factors in multiple myeloma: praticability for clinical practice and future perspectives. Leukemia, Basinastoke, v. 1 1, p. 5-9, 1997. Supplement.

LICHTMAN, M.A. Essential and secondary monoclonal gamapaties. In: WILLIANS, R.C. (Ed). Hematology. 4.ed. New York: McGraw Hill, 1990. Capitulo 121, p.1109-1114.

LIMA, A.D. Eletroforese e Imunoeletroforese. In: LIMA, A.D. (Ed.). Métodos de laborat6rio aplicados å clinica. 7.ed. Rio de Janeiro Guanabara Koogan, 1992. Capitulo 3, p. 18.1-18.8.

MALACRIDA, V. et al. Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital. J Clin Pathol, London, v.40, p.793-795, 1987.

MERLINI G. et al. Acute phase proteins and prognosis in multiple myeloma. Br J Haematol, Oxford, v.83, n.4, p.595-601, 1993.

NAPARSTEK, Y. et al. Coexistent chronic myeloid leukemia and IgA monoclonal gammopathy: report of a case and review of the literature. Am JMed Sci, Hagerstown, v.279, p.1 1 1-113, 1980.

PATRIARCA, F.et al. Clinical features and outcome of multiple myeloma arising from the transformation of a monoclonal gamapathy of undetermined significance. Leuk Lymphoma, Chur, v.34, 1).591-596, 1999.

RAPAPORT S. 1. (Ed.). Hematologia. 2.ed. Rio de Janeiro : Roca, 1990. Capftulo 20, p.276-298.

TAKAHASHI M. et al. Ultrastructural evidence for colocalization of Kappa light chain and beta 2 -microglobulin - derived amyloids using double labelling immumogold electron microscopy. Virchows Arch, Berlin, v.429, n.6, 1996. p.383-388.

TICHY, M. et al. Ig D Paraproteinemias. Neoplasma, Bratislava, v. 40, n. l,p.59-61, 1993.

TURESSON, I. et al. Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors.BrJHaematol, Oxford, v.106, n.4, p.1005-1012, 1999.

Published

2000-12-31

How to Cite

Pires, R. M. E., Almeida, A. P. F. de, Mariotto, A., Beltrame, L. P., Pereira, C. V., Bonfiglioli, R., & Provenza, J. R. (2000). MULTIPLE MYELOMA WITH A MONOCLONAL PEAK AT BETA-GLOBULIN FRACTION: CASE REPORT. Revista De Ciências Médicas, 9(3). Retrieved from https://seer.sis.puc-campinas.edu.br/cienciasmedicas/article/view/1329

Issue

Section

Relato de Caso